Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Sci Rep ; 7: 44444, 2017 03 15.
Artigo em Inglês | MEDLINE | ID: mdl-28294152

RESUMO

Melanocortin-3 receptors (MC3R) have a contextual role in appetite control that is amplified with hypocaloric conditioning. C57BL/6J (B6) mice subjected to hypocaloric feeding schedules (HFS) exhibit compulsive behavioral responses involving food anticipatory activity (FAA) and caloric loading following food access. These homeostatic responses to calorie-poor environs are attenuated in B6 mice in which Mc3r transcription is suppressed by a lox-stop-lox sequence in the 5'UTR (Mc3rTB/TB). Here, we report that optimization of caloric loading in B6 mice subject to HFS, characterized by increased meal size and duration, is not observed in Mc3rTB/TB mice. Analysis of hypothalamic and neuroendocrine responses to HFS throughout the light-dark cycle suggests uncoupling of hypothalamic responses involving appetite-stimulating fasting-responsive hypothalamic neurons expressing agouti-related peptide (AgRP) and neuropeptide Y (Npy). Rescuing Mc3rs expression in Nkx2.1(+ve) neurons is sufficient to restore normal hypothalamic responses to negative energy balance. In addition, Mc3rs expressed in Nkx2.1(+ve) neurons are also sufficient to restore FAA and caloric loading of B6 mice subjected to HFS. In summary, MC3Rs expressed in Nkx2.1(+ve) neurons are sufficient to coordinate hypothalamic response and expression of compulsive behavioral responses involving meal anticipation and consumption of large meals during situations of prolonged negative energy balance.


Assuntos
Proteína Relacionada com Agouti/genética , Metabolismo Energético/genética , Neuropeptídeo Y/genética , Receptor Tipo 3 de Melanocortina/genética , Animais , Apetite/genética , Ingestão de Energia/genética , Homeostase , Hipotálamo/metabolismo , Camundongos , Neurônios/metabolismo , Fotoperíodo , Fator Nuclear 1 de Tireoide/genética
2.
J Neurosci ; 33(25): 10447-52, 2013 Jun 19.
Artigo em Inglês | MEDLINE | ID: mdl-23785156

RESUMO

Critical periods of developmental plasticity contribute to the refinement of neural connections that broadly shape brain development. These windows of plasticity are thought to be important for the maturation of perception, language, and cognition. Synaptic properties in cortical regions that underlie critical periods influence the onset and duration of windows, although it remains unclear how mechanisms that shape synapse development alter critical-period properties. In this study, we demonstrate that inactivation of a single copy of syngap1, which causes a surprisingly common form of sporadic, non-syndromic intellectual disability with autism in humans, induced widespread early functional maturation of excitatory connections in the mouse neocortex. This accelerated functional maturation was observed across distinct areas and layers of neocortex and directly influenced the duration of a critical-period synaptic plasticity associated with experience-dependent refinement of cortical maps. These studies support the idea that genetic control over synapse maturation influences the duration of critical-period plasticity windows. These data also suggest that critical-period duration links synapse maturation rates to the development of intellectual ability.


Assuntos
Período Crítico Psicológico , Plasticidade Neuronal/fisiologia , Sinapses/fisiologia , Proteínas Ativadoras de ras GTPase/fisiologia , Animais , Encéfalo/crescimento & desenvolvimento , Encéfalo/fisiologia , Mapeamento Encefálico , Cognição/fisiologia , Interpretação Estatística de Dados , Estimulação Elétrica , Feminino , Técnicas In Vitro , Potenciação de Longa Duração/fisiologia , Masculino , Camundongos , Neocórtex/crescimento & desenvolvimento , Neocórtex/fisiologia , Técnicas de Patch-Clamp , Comportamento Social , Tálamo/crescimento & desenvolvimento , Tálamo/fisiologia , Proteínas Ativadoras de ras GTPase/genética
3.
Neuropsychopharmacology ; 34(7): 1659-72, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19145222

RESUMO

Abnormal function of NMDA receptors is believed to be a contributing factor to the pathophysiology of schizophrenia. NMDAR subunits and postsynaptic-interacting proteins of these channels are abnormally expressed in some patients with this illness. In mice, reduced NMDAR expression leads to behaviors analogous to symptoms of schizophrenia, but reports of animals with mutations in core postsynaptic density proteins having similar a phenotype have yet to be reported. Here we show that reduced expression of the neuronal RasGAP and NMDAR-associated protein, SynGAP, results in abnormal behaviors strikingly similar to that reported in mice with reduced NMDAR function. SynGAP mutant mice exhibited nonhabituating and persistent hyperactivity that was ameliorated by the antipsychotic clozapine. An NMDAR antagonist, MK-801, induced hyperactivity in normal mice but SynGAP mutants were less responsive, suggesting that NMDAR hypofunction contributes to this behavioral abnormality. SynGAP mutants exhibited enhanced startle reactivity and impaired sensory-motor gating. These mice also displayed a complete lack of social memory and a propensity toward social isolation. Finally, SynGAP mutants had deficits in cued fear conditioning and working memory, indicating abnormal function of circuits that control emotion and choice. Our results demonstrate that SynGAP mutant mice have gross neurological deficits similar to other mouse models of schizophrenia. Because SynGAP interacts with NMDARs, and the signaling activity of this protein is regulated by these channels, our data in dicate that SynGAP lies downstream of NMDARs and is a required intermediate for normal neural circuit function and behavior. Taken together, these data support the idea that schizophrenia may arise from abnormal signaling pathways that are mediated by NMDA receptors.


Assuntos
Sintomas Comportamentais/etiologia , Sintomas Comportamentais/genética , Esquizofrenia/complicações , Esquizofrenia/genética , Proteínas Ativadoras de ras GTPase/metabolismo , Estimulação Acústica/métodos , Análise de Variância , Animais , Antipsicóticos/uso terapêutico , Comportamento Animal , Sintomas Comportamentais/tratamento farmacológico , Clozapina/uso terapêutico , Estudos Cross-Over , Modelos Animais de Doenças , Maleato de Dizocilpina/farmacologia , Antagonistas de Aminoácidos Excitatórios/farmacologia , Comportamento Exploratório/efeitos dos fármacos , Comportamento Exploratório/fisiologia , Regulação da Expressão Gênica/efeitos dos fármacos , Regulação da Expressão Gênica/genética , Inibição Psicológica , Locomoção/efeitos dos fármacos , Locomoção/genética , Transtornos da Memória/tratamento farmacológico , Transtornos da Memória/genética , Transtornos da Memória/fisiopatologia , Memória de Curto Prazo/efeitos dos fármacos , Memória de Curto Prazo/fisiologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Mutação/genética , Testes Neuropsicológicos , Reflexo de Sobressalto/efeitos dos fármacos , Reflexo de Sobressalto/genética , Esquizofrenia/tratamento farmacológico , Comportamento Social , Comportamento Estereotipado/fisiologia , Proteínas Ativadoras de ras GTPase/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA